Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 111
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03157635 | Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria | ||
| NCT02485483 | Study for Validation of Standardized Questionnaires on Depression and Investigation of the Frequency of Depression in Rheumatoid Arthritis (RA) Participants | ||
| NCT02537379 | Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection | ||
| NCT00245414 | Trial of Pegasys® in Patients With Chronic Hepatitis C | ||
| NCT00144560 | Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA) | ||
| NCT00210249 | Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment | ||
| NCT02475616 | A Single Ascending Dose Study of PCO371 in Healthy Volunteers | ||
| NCT04649216 | Excretion Balance, PK and Metabolism of a Single Oral Dose of [14C]PCO371 | ||
| NCT00060138 | Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases | ||
| NCT04861259 | A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) | ||
| NCT00433693 | Correction Study of R744 in Renal Anemia Patients on Hemodialysis | ||
| NCT01989780 | Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer | ||
| NCT00492427 | Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta) | ||
| NCT03020160 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A | ||
| NCT00144521 | Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA) | ||
| NCT00467012 | Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer | ||
| NCT00860639 | Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk | ||
| NCT00976170 | Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) | ||
| NCT02073279 | Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD) | ||
| NCT05907980 | A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors | ||
| NCT05686369 | A Decentralized Home-Based Study To Investigate Novel Objective Biomarker Of Gluten-Mediated Symptoms In Celiac Disease Participants (CeDar ROSE Study) | ||
| NCT05022927 | A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma | ||
| NCT01986933 | A Phase 2 Study of CIM331 for Atopic Dermatitis Patients | ||
| NCT06819891 | A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease | ||
| NCT02028884 | Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) | ||
| NCT04740905 | A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion | ||
| NCT05012618 | A Dose-escalation Study of LUNA18 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion). | ||
| NCT00548548 | A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer | ||
| NCT02622321 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors | ||
| NCT00144469 | A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C | ||
| NCT04732598 | A Phase III Study of Bevacizumab and Paclitaxel in Combination with Atezolizumab As a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer | ||
| NCT05503264 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis | ||
| NCT00144573 | Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment | ||
| NCT00144495 | A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy | ||
| NCT05433207 | Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal Osteoporosis | ||
| NCT06497556 | A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer | ||
| NCT04818983 | The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2) | ||
| NCT00661284 | A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.) | ||
| NCT00491868 | Clinical Study of R744 to Hemodialysis Patients | ||
| NCT04097444 | CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC | ||
| NCT04209179 | A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism | ||
| NCT05271409 | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease | ||
| NCT06793215 | A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer | ||
| NCT01817699 | Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients | ||
| NCT00779220 | A Study to Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis | ||
| NCT02431117 | Non-drug Study to Assess the Suitability of Assessment Scales in Japanese Individuals With Down Syndrome Aged 6-30 | ||
| NCT07107490 | A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER | ||
| NCT00237211 | Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer | ||
| NCT02101333 | Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis | ||
| NCT06819878 | A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease |
